Influenza B virus B/Maryland/15/2016 BX-69A antigen (formaldehyde inactivated)

DB14559ApprovedInvestigationalVaccines

Influenza B virus B/Maryland/15/2016 BX-69A antigen (formaldehyde inactivated) is an influenza antigen used in seasonal influenza vaccines. A seasonally-specific component of the influenza vaccine.

First approval
United States, 2018
Brand names
  • Fluzone High-dose
  • Fluzone Quadrivalent

Resolves to

Compound
UNIIM691J375MM

What you can answer from here — as of April 02, 2025

11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4ContraindicationsEach with its own population and attribute set
Sign in
20Marketed productsAcross 5 countries and 4 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Influenza B virus B/Maryland/15/2016 BX-69A antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In